iCAD, Inc. (ICAD)
-NasdaqCM 5.96 
0.20(3.47%) May 17, 4:00PM EDT
| Prev Close: | 5.76 |
|---|
| Open: | 5.80 |
|---|
| Bid: | 4.83 x 1000 |
|---|
| Ask: | 5.98 x 100 |
|---|
| 1y Target Est: | 9.00 |
|---|
| Beta: | 0.85 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 5.75 - 5.96 |
|---|
| 52wk Range: | 1.75 - 6.90 |
|---|
| Volume: | 23,514 |
|---|
| Avg Vol (3m): | 43,976 |
|---|
| Market Cap: | 64.58M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.73 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ICAD INC FinancialsEDGAR Online Financials(Fri, May 17)
- ICAD INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- ICAD INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Mon, May 6)
- iCAD’s Xoft Intraoperative Radiation Therapy System Featured at American Society of Breast Surgeons ConferenceBusiness Wire(Fri, May 3)
- ICAD's Double-Digit Growth Looks Sustainableat Seeking Alpha(Wed, May 1)
- iCAD's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 30)
- icad, Inc Earnings Call scheduled for 10:00 am ET todayCCBN(Tue, Apr 30)
- iCAD Reports First Quarter Financial ResultsBusiness Wire(Mon, Apr 29)
- Q1 2013 icad, Inc Earnings Release - After Market CloseCCBN(Mon, Apr 29)
- iCAD to Present at the 12th Annual Needham Healthcare ConferenceBusiness Wire(Wed, Apr 24)
- iCAD Announces Poster Presentation of Xoft System to Treat Skin Cancer Highlighted at 2013 American Brachytherapy Society Annual MeetingBusiness Wire(Thu, Apr 18)
- iCAD to Host First Quarter Financial Results Conference Call on Tuesday, April 30, 2013Business Wire(Mon, Apr 15)
- iCAD Expands Global Distribution of the Xoft Electronic Brachytherapy System with Agreements in Asia and RussiaBusiness Wire(Tue, Apr 9)
- iCAD Announces FDA Clearance of Cervical Applicator for Xoft Electronic Brachytherapy SystemBusiness Wire(Wed, Mar 20)
- iCAD and Invivo Announce Global Strategic Agreement to Deliver MRI Solutions WorldwideBusiness Wire(Mon, Mar 11)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.09 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.78 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.25 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | -0.49 |
|---|
Business Summary
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy that enable healthcare professionals and radiologists to identify pathologies and pinpoint cancer earlier.
View More